Daily aspirin use and cancer mortality in a large US Cohort

Journal of the National Cancer Institute

Volumn 104, Issue 16, 2012, Pages 1208-1217

  Jacobs, Eric J ^a   Newton, Christina C ^a   Gapstur, Susan M ^a   Thun, Michael J ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; RISK FACTOR; UNITED STATES;

ADULT; AGED; ANTICARCINOGENIC AGENTS; ASPIRIN; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RESEARCH DESIGN; RISK; UNITED STATES;

EID: 84865508408     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs318     Document Type: Article

References (29)

1. R othwell PM, Price JF, Fowkes FG, et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet. 2012;379(9826):1602-1612.
2. Seshasai SR, Wijesuriya S, Sivakumaran R, et al. Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. Arch Intern Med. 2012;172(3):209-216.
3. Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005;294(1):47-55. (Pubitemid 41002838)
4. T hun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr. Aspirin use and risk of fatal cancer. Cancer Res. 1993;53(6):1322-1327. (Pubitemid 23097110)
5. Bardia A, Ebbert JO, Vierkant RA, et al. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality. J Natl Cancer Inst. 2007;99(11):881-889. (Pubitemid 47073510)
6. Chan AT, Manson JE, Feskanich D, Stampfer MJ, Colditz GA, Fuchs CS. Long-term aspirin use and mortality in women. Arch Intern Med. 2007;167(6):562-572. (Pubitemid 46513225)
7. Bosetti C, Rosato V, Gallus S, et al. Aspirin and cancer risk: a quantitative review to 2011 [published online ahead of print April 19, 2012]. Ann Oncol 2012; doi: 10.1093/annonc/mds113.
8. Calle EE, Rodriguez C, Jacobs EJ, et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer. 2002;94(9):2490-2501. (Pubitemid 34457132)
9. American Cancer Society Cancer Prevention Study Questionnaires. http://www.cancer.org/Research/ResearchProgramsFunding/Epidemiology- CancerPreventionStudies/StudyQuestionnaires/index. Accessed June 1, 2012.
10. World Health Organization. International Classification of Diseases. 9th revision. Geneva: World Health Organization; 1977.
11. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th revision. Geneva: World Health Organization; 1992.
12. Calle EE, Terrell DD. Utility of the national death index for ascertainment of mortality among cancer prevention study II participants. Am J Epidemiol. 1993;137(2):235-241. (Pubitemid 23083676)
13. Cox DR. Regression models and life tables (with discussion). J R Statist Soc B. 1972;34(2):187-220.
14. Kleinbaum DG. Survival Analysis: A Self-Learning Text. New York: Springer-Verlag; 1996.
15. H osmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley; 1989.
16. Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res. 2003;35(11-12):694-704. (Pubitemid 38058173)
17. Donohoe CL, Doyle SL, Reynolds JV. Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr. 2011;3:12.
18. Jacobs EJ, Thun MJ, Bain EB, Rodriguez C, Henley SJ, Calle EE. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst. 2007;99(8):608-615. (Pubitemid 47073542)
19. H olmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE. Aspirin intake and survival after breast cancer. J Clin Oncol. 2010;28(9):1467-1472.
20. Chan AT, Ogino S, Fuchs CS. Aspirin use and survival after diagnosis of colorectal cancer. JAMA. 2009;302(6):649-658.
21. Choe KS, Correa D, Jani AB, Liauw SL. The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy. Cancer. 2010;116(7):1820-1826.
22. Ikonomidis I, Lekakis J, Vamvakou G, Andreotti F, Nihoyannopoulos P. Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. Am Heart J. 2005;149(5):832-839. (Pubitemid 40718878)
23. E ikelboom JW, Hankey GJ, Thom J, et al.; Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) Investigators. Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. Circulation. 2008;118(17):1705-1712.
24. T hun MJ, Jacobs EJ, Patrono C. The role of aspirin in cancer prevention. Nat Rev Clin Oncol. 2012;9(5):259-267.
25. Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011;11(2):123-134.
26. Baigent C, Blackwell L, Collins R, et al.; Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849-1860.
27. Brunton L, ed. Goodman and Gilman's the Pharmacologic Basis of Therapeutics. 11th ed. New York, NY: McGraw Hill; 2006.
28. E l-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557-2576. (Pubitemid 46890874)
29. R othwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011;377(9759):31-41.